Next Article in Journal
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111In)/Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels
Next Article in Special Issue
Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study
Previous Article in Journal
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors
Previous Article in Special Issue
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients
 
 
Systematic Review

Article Versions Notes

Cancers 2021, 13(11), 2827; https://doi.org/10.3390/cancers13112827
Action Date Notes Link
article xml file uploaded 6 June 2021 10:30 CEST Original file -
article xml uploaded. 6 June 2021 10:30 CEST Update -
article pdf uploaded. 6 June 2021 10:30 CEST Version of Record https://www.mdpi.com/2072-6694/13/11/2827/pdf-vor
article xml file uploaded 6 June 2021 10:31 CEST Update -
article xml uploaded. 6 June 2021 10:31 CEST Update -
article pdf uploaded. 6 June 2021 10:31 CEST Updated version of record https://www.mdpi.com/2072-6694/13/11/2827/pdf-vor
article html file updated 6 June 2021 10:32 CEST Original file -
article pdf uploaded. 23 June 2021 04:18 CEST Updated version of record https://www.mdpi.com/2072-6694/13/11/2827/pdf
article xml uploaded. 23 June 2021 04:18 CEST Update https://www.mdpi.com/2072-6694/13/11/2827/xml
article html file updated 23 June 2021 04:19 CEST Update -
article html file updated 26 July 2022 23:04 CEST Update https://www.mdpi.com/2072-6694/13/11/2827/html
Back to TopTop